These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3606350)

  • 1. Synthesis and estrogen receptor affinity of 2,3-diarylindoles.
    Strohmeier J; von Angerer E
    Arch Pharm (Weinheim); 1987 May; 320(5):407-17. PubMed ID: 3606350
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological activity of 4-methylestradiol.
    Qian XD; Abul-Hajj YJ
    J Steroid Biochem; 1990 May; 35(6):745-7. PubMed ID: 2362436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists.
    von Angerer E; Knebel N; Kager M; Ganss B
    J Med Chem; 1990 Sep; 33(9):2635-40. PubMed ID: 2391702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
    Biberger C; von Angerer E
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma.
    Horn DW; Vollmer G; von Angerer E; Schneider MR
    Int J Cancer; 1994 Aug; 58(3):426-9. PubMed ID: 8050824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes.
    Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H
    J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-(4-hydroxyphenyl)-N-(1,1,1-trifluor-2-propyl)-4-hydroxyben zamide: synthesis and pharmacologic evaluation of a new antiestrogen].
    Hartmann RW; vom Orde HD; Heindl A; Schönenberger H
    Arch Pharm (Weinheim); 1988 Aug; 321(8):497-501. PubMed ID: 3223808
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic and antiestrogenic activity of monophenolic analogues of tamoxifen, (Z)-2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N, N-dimethylethylamine.
    Ruenitz PC; Bagley JR; Mokler CM
    J Med Chem; 1982 Sep; 25(9):1056-60. PubMed ID: 7131484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor.
    Rochefort H; Garcia M; Borgna JL
    Biochem Biophys Res Commun; 1979 May; 88(2):351-7. PubMed ID: 465043
    [No Abstract]   [Full Text] [Related]  

  • 17. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumors.
    Erber S; von Angerer E
    Arch Pharm (Weinheim); 1990 Sep; 323(9):591-4. PubMed ID: 2288481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.